122 results
Page 2 of 7
8-K
EX-10.1
912gmkh0lxjp6tp
18 May 22
Departure of Directors or Certain Officers
8:11am
S-8
EX-107
agxd0c52
1 Apr 22
Registration of securities for employees
8:01am
8-K
EX-3.2
q30e8 bg5dfyzsnr
15 Mar 22
NCI achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of the study
8:01am
8-K
EX-3.1
ihtam6nnvk oxvj
15 Mar 22
NCI achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of the study
8:01am
DEFA14A
ittbfm11qijybxawf q5
27 Dec 21
Additional proxy soliciting materials
4:15pm
PRE 14A
m79xa7urilf es
30 Nov 21
Preliminary proxy
5:16pm
8-K
EX-10.1
9rzkdfj4
6 Oct 21
Departure of Directors or Certain Officers
8:45am
8-K
EX-1.1
v3e9f74
17 Jun 21
PDS Biotech Announces Proposed Offering of Common Stock
12:00am